Resultados financieros en millones de dólares estadounidenses. El ejercicio fiscal es febrero - enero.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Ingresos
35
41
24
44
27
9
Crecimiento de los Ingresos (YoY)
-15%
71%
-45%
63%
200%
-67%
Costo de los ingresos
18
17
10
14
10
4
Utilidad bruta
17
24
14
29
16
5
Venta, General y Administración
15
12
10
11
9
9
Investigación y Desarrollo
7
4
3
3
3
4
Gastos de Operación
22
16
14
14
12
13
Otras Ingresos (Gastos) No Operativos
--
--
--
--
--
--
Ingreso antes de impuestos
-4
9
0
27
4
-6
Gasto por Impuesto a la Renta
-1
2
0
3
--
0
Ingreso Neto
-3
6
0
24
4
-6
Crecimiento de la Utilidad Neta
-133%
--
-100%
500%
-167%
500%
Acciones en Circulación (Diluidas)
16.32
16.35
16.26
16.62
16.5
16.43
Cambio de Acciones (YoY)
0%
1%
-2%
1%
0%
1%
EPS (Diluido)
-0.18
0.4
0.02
1.46
0.25
-0.42
Crecimiento de EPS
-132%
1,263%
-98%
484%
-160%
320%
Flujo de efectivo libre
2
-1
-2
-1
0
0
Flujo de efectivo libre por acción
--
--
--
--
--
--
Margen bruto
48.57%
58.53%
58.33%
65.9%
59.25%
55.55%
Margen de operación
-14.28%
19.51%
0%
31.81%
14.81%
-88.88%
Margen de beneficio
-8.57%
14.63%
0%
54.54%
14.81%
-66.66%
Margen de flujo de caja libre
5.71%
-2.43%
-8.33%
-2.27%
0%
0%
EBITDA
-5
8
0
14
4
-8
Margen de EBITDA
-14.28%
19.51%
0%
31.81%
14.81%
-88.88%
D&A para EBITDA
0
0
0
0
0
0
EBIT
-5
8
0
14
4
-8
Margen de EBIT
-14.28%
19.51%
0%
31.81%
14.81%
-88.88%
Tasa de Impuesto Efectiva
25%
22.22%
0%
11.11%
--
0%
Estadísticas clave
Cierre Anterior
$4.76
Precio de apertura
$4.85
Rango del día
$3.71 - $4.98
Rango de 52 semanas
$3.03 - $9.07
Volumen
112.3K
Volumen promedio
101.8K
EPS (TTM)
-0.18
Rendimiento de dividendos
--
Cap. de mercado
$60.9M
¿Qué es SRTS?
Sensus Healthcare, Inc. is a medical device company, which engages in the provision of treatment for both oncological and non-oncological skin conditions. The company is headquartered in Boca Raton, Florida and currently employs 35 full-time employees. The company went IPO on 2016-06-03. The Company, leveraging its superficial radiotherapy (SRT and IG-SRT) technology, provides healthcare providers with a patient-centric treatment platform. Its products and services include SRT-100, SRT-100 Vision, SRT-100+, Sentinel service program and others. The SRT-100 is a photon x-ray low energy SRT system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides customers with additional options compared to the SRT-100 base model. These additional options allow for dedicated treatment planning and full treatment progression documentation in a patient’s record. The SRT-100+ offers all the same features as the SRT-100, with the addition of remote diagnostics and other features.